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Evolutionary conservationPax3 is a transcription factor expressed in somitic mesoderm, dorsal neural tube and pre-migratory neural
crest during embryonic development. We have previously identiﬁed cis-acting enhancer elements within the
proximal upstream genomic region of Pax3 that are sufﬁcient to direct functional expression of Pax3 in
neural crest. These elements direct expression of a reporter gene to pre-migratory neural crest in transgenic
mice, and transgenic expression of a Pax3 cDNA using these elements is sufﬁcient to rescue neural crest
development in mice otherwise lacking endogenous Pax3. We show here that deletion of these enhancer
sequences by homologous recombination is insufﬁcient to abrogate neural crest expression of Pax3 and
results in viable mice. We identify a distinct enhancer in the fourth intron that is also capable of mediating
neural crest expression in transgenic mice and zebraﬁsh. Our analysis suggests the existence of functionally
redundant neural crest enhancer modules for Pax3.., Philadelphia, PA 19104. Fax:
pstein).
ll rights reserved.© 2009 Elsevier Inc. All rights reserved.Introduction
Pax3 is a paired-domain containing nuclear transcription factor
that is required for normal neural crest and skeletal muscle
development. Mutation of Pax3 results in embryonic lethality and
multiple defects in tissues of neural crest and somitic origin as seen in
the naturally occurring Splotch mutant (Auerbach, 1954). In humans,
mutations in PAX3 result in Waardenburg syndrome which is
characterized by neural crest abnormalities (Tassabehji et al., 1993).
We and others have sought to better understand gene regulation in
this critical tissue through analysis of cis-acting elements in the Pax3
locus. Toward this end, 1.6 Kb of genomic sequence upstream of
the Pax3 transcription start site has been found to be capable of
driving reporter gene expression in the neural crest of transgenicmice(Li et al., 1999; Natoli et al., 1997; Pruitt, 1994). The use of this genomic
region to express Pax3 in transgenic mice is well tolerated and is
sufﬁcient to rescue neural crest defects in Splotch mice, including
conotruncal cardiac abnormalities (Li et al., 1999). Furthermore, we
have shown that transgenic mice in which the 1.6 Kb Pax3 upstream
genomic region directs expression of Cre recombinase can be used to
fate-map neural crest derivatives when crossed with appropriate Cre
reporter mice (Li et al., 2000). A distinct upstream enhancer that
mediates hypaxial somite expression of Pax3 has also been identiﬁed
more than 6 Kb upstream of the transcription start site (Brown et al.,
2005).
The 1.6 Kb Pax3 upstream region contains two evolutionarily
conserved elements that are critical for the neural crest expression
(Milewski et al., 2004; Pruitt et al., 2004). These two conserved
elements, each about 250 bp in length, are located within a 674 bp
region that we heretofore refer to as “NCE” (neural crest element).
The NCE contains a binding site for the transcription factor Tead2
which we have shown is co-expressed with Pax3 in the dorsal
neural tube and which, along with its co-activator YAP65, can
regulate Pax3 expression (Milewski et al., 2004). However, more
recent inactivation of Tead2 in mice failed to signiﬁcantly alter Pax3
expression although neural tube defects were produced (Kaneko et
al., 2007). Taken together with our prior work showing the
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activation in transgenic mice, this suggests the existence of
redundant mechanisms for regulation of Pax3 neural crest expres-
sion outside the NCE.
Here, we show that targeted deletion of the Pax3 NCE does not
detectably alter Pax3 expression and results in viable mice. The NCE
was targeted using a ﬂoxed PGK-neo cassette which, when left in
place, disrupts Pax3 expression thus producing a new allele of Splotch.
Removal of the PGK-neo cassette with various cre-expressing mice
allows for tissue-speciﬁc rescue of Pax3 function. We identify a
previously unrecognized enhancer in the fourth Pax3 intron that
directs neural tube and neural crest expression, and functions
redundantly with the upstream NCE in transgenic mice. Sequence
analysis reveals the presence of NFY and Lef1 binding sites in both
neural crest enhancer elements that are maintained through
evolution.Fig. 1. Targeted deletion of the Pax3 upstream NCE. (A) Schematic representation of targeti
(neo) to produce the Pax3NCE-neo allele after homologous recombination. Cre recombinase re
(B and C). Conﬁrmation of targeted ES cells (B) andmice (C) by Southern blot using a probe 3
by PCR. (E) Pax3NCE-neo/+ mice have white belly spots. (F) Pax3NCE-neo/NCE-neo E13.5 embryoExperimental procedures
Gene targeting and generation of neural crest enhancer deleted mice
The targeting construct involved modiﬁcation of pPNT containing
an HSV-TK cassette for negative selection. The targeting strategy
involved deletion of a 674 bp neural crest enhancer region
(corresponding to position 21231-20621 of GenBank AC084043)
previously described (Li et al., 1999; Milewski et al., 2004) and
replacement with a ﬂoxed PGK-neo cassette (Fig. 1A).
Synthesis of the 5′ homology arm was accomplished by PCR using
the primers:
5′ forward, 5′-CCCGGCGCGCCGCTATGCAGATTACATTTCCTACG-
TATCCC-3′;
5′ reverse, 5′-GGTGACCCTCACTTGAGAATTTCCCGGTCG-
GAGCTCGGC-3′.ng strategy. The NCE (orange box) is replaced by a ﬂoxed neomycin resistance cassette
moves the neomycin cassette, leaving a single loxP site (triangle), to produce Pax3NCE.
′ of the targeting arms. (D) After cre recombination, the removal of the NCE is conﬁrmed
s have neural tube defects (white arrowheads).
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the primer:
3′ forward, 5′-GCCGTTAACTTCAGCTTGCAACTTGGAGCCCAGGG-
GAGG-3′
3′ reverse, 5′-GCCTTAATTAAGGCCTGCCGTTGATAAATACTCCTCC-
GAGC-3′.
The targeting construct was used to electroporate R1 ES cells
(kindly provided by Andras Nagy, Mount Sinai Medical Center,
Toronto, Canada) producing 13 of 412 clones that were correctly
targeted as assessed by Southern blot, and 3 were injected into B6SJLF
blastocysts producing 9 chimeric founders. Germline transmission for
the heterozygous Pax3NCE-neo/+ (neural crest enhancer deleted with
neo) allele was conﬁrmed by Southern blot. Pax3NCE/+ mice (neural
crest enhancer deleted, neo removed) and Pax3NCE-neomice were bred
to BALB/c-TgN(CMV-Cre)1Cgn (Stock Number 003465, Jackson
Laboratory) on a CD1 background as well as B6.FVB-Tg(EIIa-cre)
C5379Lmgd/J (stock number 003724, Jackson Laboratory) mice on a
B6 background and removal of the neo cassette was conﬁrmed by PCR.
Genotyping of embryos and mice
Genotyping Pax3NCE-neo and Pax3NCE was performed by PCR using
the following primers:
Pax3 upstream forward: 5′-CTGAGTGTGCAGCCTGAATTTAACCA-
CTTG-3′
Pax3 downstream reverse: 5′-AAGACCCTCCGAGTGTATCCCTCGC-
GTCCG-3′
neo forward: 5′-TTCAAAAGCGCACGTCTGCCGCGC-3′ .
This strategy generated a 1.3Kb wild-type band and a 600 bp band
when the ﬂoxed neo cassette was present in place of the neural crest
enhancers. A 400 bp band was produced when the ﬂoxed neo cassette
was deleted by cre-mediated recombination.
Genotyping for lacZ was performed by PCR using the following
primers:
lacZ genotype forward: 5′-ATCACGACGCGCTGTATCGCTG-3′
lacZ genotype reverse: 5′-CACTGAGGTTTTCCGCCAG-3′ .
The presence of the lacZ gene results in a 783 bp product.Wnt1-cre
(Jiang et al., 2002), Pax3Cre (Engleka et al., 2005) and P34TKZ Pax3
reporter (Relaix et al., 2004) mice have been described.
Generation of transgenic mice
An evolutionarily conserved region of the Pax3 genomic locus in
the fourth intron, termed ECR2, was ampliﬁed by PCR using the
following primers:
Pax3 int forward: 5′-GGCTCGAGGAGGGGATGTGCTATTTGA-
GATTTCGG-3′
Pax3 int reverse: 5′-GGCTCGAGGTGTATTCACCTAGTCCATTTGAT-
GATTGG-3′ .
Theseprimers amplify the region corresponding to chr1:78,164,002-
78,164,969 of the mouse July 2007 NCBI Build 37 mouse genome
assembly (mm9). Primer sequences for ampliﬁcation of additional
evolutionary conserved regions of the Pax3 locus are provided in
supplemental methods. The ampliﬁed regions were subcloned up-
stream of the lacZ gene with either an hsp68 minimal promoter or a
promoter region derived from the endogenous Pax3 gene, as described
in the results section. Transgenic mice were generated by injection of
linearized DNA into the male pronucleus of C57BL6xSJL-F1/J zygotes.
Embryos were harvested at E10.5 for analysis of ß-galactosidase
expression and genotype.Generation of transgenic zebraﬁsh
The evolutionarily conserved region (ECR2) of the Pax3 genomic
locus was PCR ampliﬁed using the attB1int4-3 F (5′-GGGGACAAGTTTG-
TACAAAAAAGCAGGCTGAGGGGATGTGCTATTTGAGATTTCGG-3′)/attB2
int4-3 R (5′-GGGGACCACTTTGTACAAGAAAGCTGGGTGTGTATTCACC-
TAGTCCATTTGATGATTGG-3′) primer pair, cloned into pDONR221
(Invitrogen) by Gateway recombination, and the resulting plasmid
was designated pME-ECR2. The Lef1/TCF binding sites in pME-ECR2
were mutated by synthesis of a 403-bp sequence-veriﬁed Bsu36I/BsaI
ﬂanked miniGene (Integrated DNA Technology) engineered to harbor
mutations in all of the Lef1/TCF sites, Bsu36I/BsaI restriction digestion,
and ligation of this fragment into a Bsu36I/BsaI restriction digested
pME-ECR2 vector backbone, thus generating the plasmid designated
pME-ECR2ΔLef. pME-ECR2was then recombined into thepGW_cfosEGFP
and pGW_cfosmCherry Tol2 transgenic expression plasmids (Fisher et
al., 2006) by LR recombination (Invitrogen); pME-ECR2ΔLef was cloned
into pGW_cfosmCherry.Wild-type and Tg(sox10:GFP) (Antonellis et al.,
2008) zebraﬁsh embryos were injected with an approximately 2 nl
volume containing 10 pg of the appropriate transgenic expression
plasmidand35pgof transposaseRNAsuspended innuclease-freewater
supplemented with phenol red (10% v/v).
β-galactosidase staining
Embryos were ﬁxed with 2% paraformaldehyde in PBS for 5–15
min on ice. After washing brieﬂy in PBS, they were stained in 1 mg/ml
X-gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.01% NP-40,
0.01% sodium deoxycholate, in PBS. Staining reactions were carried
out for 2 h to overnight at 37 °C.
Histology and immunohistochemistry
Embryos were harvested and ﬁxed in 4% paraformaldehyde for
24 h, then dehydrated in 100% ethanol, ﬁxed in parafﬁn and sectioned.
The Pax3 and MyoD (D7F2) monoclonal antibodies generated by C.
Ordahl and J. Gurdon, respectively, were obtained from the Develop-
mental Studies Hybridoma Bank developed under the auspices of the
NICHD and maintained by The University of Iowa, Department of
Biology, Iowa City, IA 52242. For LacZ and Pax3 double staining,
embryos were stained for β-galactosidase as described above. The
embryos were then dehydrated in methanol. Pax3 whole mount
immunohistochemistry was carried out using a standard protocol as
previously described (Singh et al., 2005). Brieﬂy, embryos were
rehydrated and probed with Pax3 antibody overnight at 4 °C at a
dilution of 1:100. The secondary antibody was goat-anti-mouse IgG-
HPR (Santa Cruz biotechnology sc-2005) used at a dilution of 1:1000
for 4 h at room temperature. After washing, signals were detected
using diaminobenzidine and H2O2.
Results
Targeted deletion of the neural crest enhancer region
We have previously identiﬁed two ∼250 bp enhancer elements
within the upstream Pax3 genomic region that are sufﬁcient to
recapitulate the Pax3 expression pattern in the neural crest, and to
direct functional expression of Pax3 (Li et al., 1999; Milewski et al.,
2004). We sought to test whether these enhancer elements are also
necessary in vivo for Pax3 expression in the neural crest. Here, we
refer to these upstream neural crest elements collectively as “NCE.”
We generated a mutant Pax3 allele in which a 674 bp region,
which encompasses the NCE (Milewski et al., 2004), was deleted
using homologous recombination. The targeted allele resulted in the
replacement of the NCE with a PGK-neo cassette ﬂanked by loxP sites
(Fig. 1A), and we designated this allele Pax3NCE-neo. Appropriate
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3 independent clones were used to generate chimeras, which
subsequently yielded germline transmission of the targeted Pax3
allele, as assessed by Southern blotting (Fig. 1C) and PCR (Fig. 1D).
Replacement of the NCE with PGK-neo results in loss of Pax3 expression
Pax3NCE-neo/+mice displayed a coat color defect characterized by a
white belly spot (Fig. 1E) similar to that seen in Splotch heterozygous
mice carrying a null allele for Pax3 (Auerbach, 1954). Pax3NCE-neo/+
mice otherwise appeared normal and were viable and fertile.
Intercrosses of Pax3NCE-neo/+ mice were established but failed to
yield any viable Pax3NCE-neo/NCE-neo homozygous offspring among
more than 20 litters, suggesting embryonic lethality. Therefore, timed
matings were established and embryos were harvested at E12.5, just
prior to the time of embryonic lethality for Pax3-deﬁcient Splotch
homozygotes (Auerbach, 1954). At E12.5, Pax3NCE-neo/NCE-neo embryos
were identiﬁed in the expected Mendelian ratios (17 of 66 embryos
genotyped). Pax3NCE-neo/NCE-neo embryos exhibited exencephaly and
spina biﬁda (Fig. 1F). Hypaxial muscle development was also
markedly deﬁcient, as evidenced by the lack of MyoD-expressing
myoblasts in the developing limbs (Figs. 2A and B) and by routine
histology and gross inspection (data not shown). These abnormalities
are similar to those seen in homozygous Splotch embryos (Auerbach,
1954) and suggest severe loss of Pax3 function. Direct examination of
Pax3 expression by immunohistochemistry showed a drastic reduc-
tion or complete loss of Pax3 protein in Pax3NCE-neo/NCE-neo embryos
(Figs. 2C, D). Conotruncal cardiac defects including persistent truncus
arteriosus were also seen (Figs. 2E, F) consistent with the Splotch
phenotype and loss of Pax3 function in cardiac neural crest. Hence,Fig. 2. Pax3NCE-neo/NCE-neo embryos display cardiac and limb muscle defects at E12.5.
(A and B). Immunohistochemistry with a MyoD antibody reveals hypaxial myoblasts
(black arrow) that have appropriatelymigrated to the limb in thewild-type embryo (A),
while no MyoD positive cells are detected in the limb of the Pax3NCE-neo/NCE-neo mutant
(B). Epaxial myoblasts expressing MyoD (arrowhead) are present. (C and D). Pax3
protein is expressed in the dorsal neural tube of wild-type (C) but not Pax3NCE-neo/NCE-neo
(D) embryos. (E and F) H&E staining reveals septation of the aorta (Ao) and pulmonary
artery (PA) in wild-type embryo (E), while the truncus arteriosus (TA) is unseptated in
the Pax3NCE-neo/NCE-neo littermate (F). Scale bar=200 μm.Pax3NCE-neo represents a new allele of Splotch and a null or severely
hypomorphic allele of Pax3.
Removal of the PGK-neo cassette restores Pax3 expression
To determine if the phenotype observed in Pax3NCE-neo/NCE-neo
embryos was related to the presence of the PGK-neo cassette, the
heterozygous Pax3NCE-neo/+ mice were crossed with transgenic mice
ubiquitously expressing Cre in order to remove the ﬂoxed PGK-neo
cassette in all tissues (Fig. 3). Heterozygous mice with the PGK-neo
cassette removed, designated Pax3NCE/+, had no obvious phenotypes
and no coat color abnormalities. Surprisingly, homozygous Pax3NCE/NCE
mice also appeared normal, are born in the expected Mendelian ratios
(Table 1), and are fertile. Immunohistochemistry of E11.5 Pax3NCE/NCE
embryos revealed apparently normal level and distribution of Pax3
protein compared towild-type littermates (Figs. 3A and B). Septation of
the outﬂow tract, a process that requires Pax3 function in cardiac neural
crest,wasnormal (Figs. 3C andD) aswasneural tube closure, dorsal root
ganglia development, and skeletal muscle formation as assessed by
routine histology (Fig. 3 and data not shown).
In addition to extensive phenotyping and analysis of Pax3 protein
expression in various tissues in the embryo and adult, we also sought
to identify subtle abnormalities of Pax3 function by examining
transcriptional activity in vivo. We crossed Pax3NCE/NCE to a transgenic
P34TKZ Pax3 reporter line (Relaix et al., 2004) that contains
concatamers of Pax3 binding sites upstream of lacZ, and expresses
β-galactosidase in Pax3 expressing tissues (Fig. 3E). Homozygous
Pax3NCE/NCE mice show the same pattern of β-galactosidaseFig. 3. Removal of the PGK-neo cassette restores Pax3 expression, and results in normal
conotruncal anatomy and Pax3 transcriptional activity despite the loss of the NCE.
(A and B) Immunohistochemistry reveals normal Pax3 expression in the dorsal neural
tube of an E12.5 Pax3NCE/NCE embryo (B) as compared to wild type (A). (C and D) Both
wild-type (C) and Pax3NCE/NCE (D) mice have normal septation of the aorta (Ao) and
pulmonary artery (PA) at E12.5. (E and F) X-gal staining of P34TKZ Pax3 reportermice at
E11.5 reveals normal expression of β-galactosidase in the neural crest (white arrow)
and somites (black arrowhead) in wild-type (E) and Pax3NCE/NCE (F) mice. Scale
bar=200 μm.
Table 1
Genotypes of offspring from Pax3NCE/+×Pax3NCE/+ matings at weaning.
Pax3+/+ Pax3NCE/+ Pax3NCE/NCE Total
Actual 33 (24%) 66 (48%) 38 (28%) 137
Predicted 34 (25%) 69 (50%) 34 (25%)
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transcriptional activity throughout the embryo. We also sought to
determine if Pax3NCE/NCE mice have defects in adult melanocytes, but
failed to detect any abnormalities induced by depilation of hair or
tanning (data not shown). Thus, it appears that the 674 bp NCE region
in the Pax3 promoter that is sufﬁcient to direct neural crest expression
in transgenic mice is not required for Pax3 expression or transcrip-
tional activity in vivo.Fig. 4. Restoration of Pax3 expression in neural crest rescues embryonic development.
(A and B) Wnt1-cre, Pax3NCE-neo/NCE-neo mice survive to birth, but occasionally display
spina biﬁda (B) not seen in control littermates (A). (C–F) H&E staining of newborns
shows normal septation of the aorta (Ao) and pulmonary artery (PA) in both wild-type
(C) and Wnt1-cre, Pax3NCE-neo/NCE-neo mice (D), but severe deﬁciency of forelimb
musculature in Wnt1-cre, Pax3NCE-neo/NCE-neo mice (arrow, F) as compared to wild typeThe Pax3NCE-neo allele allows for tissue-speciﬁc rescue of Pax3 expression
These results indicate that Pax3NCE-neo acts as a null allele while
removal of the ﬂoxed PGK-neo cassette restores functional levels of
Pax3 expression. Hence, we sought to demonstrate that tissue-speciﬁc
expression of cre recombinase would allow for tissue-speciﬁc rescue
of Pax3 expression. As a ﬁrst step, we crossed Pax3NCE-neo/+ mice to
Pax3Cre/+ mice in which cre recombinase is knocked into the Pax3
locus (Engleka et al., 2005), and Pax3NCE-neo/Cre offspring were
generated. We have previously shown that the Pax3Cre allele is a
null allele of Pax3 (Engleka et al., 2005). Hence, Pax3NCE-neo/Cre mice
can only be viable if cre-mediated removal of the PGK-neo cassette in
the Pax3NCE-neo allele restores Pax3 expression in critical tissues and at
critical time points. Pax3NCE-neo/Cre mice were viable and had normal
development of neural crest derivatives, including normal cardiac
outﬂow tract and aortic arch derivatives (Supplemental Fig. 1A and B).
These mice also demonstrated normal hypaxial muscle development
(Supplemental Fig. 1C). Thus, the Pax3NCE-neo/+ mouse can be used as
a genetic tool to delineate the tissue-speciﬁc role of Pax3.(arrow, E). Scale bar=200 μm.Restoration of Pax3 expression in neural crest rescues embryonic
lethality
Next, we sought to investigate the effects of tissue-speciﬁc rescue
of Pax3 expression in neural crest by crossing Pax3NCE-neo/+mice with
Wnt1-cre, Pax3+/−mice to produceWnt1-cre, Pax3NCE-neo/− offspring,
which would be predicted to have normal Pax3 expression in neural
crest but deﬁcient Pax3 expression in somites. Wnt1 is expressed in
the dorsal neural tube and neural crest progenitors. The Wnt1
promoter/enhancer has been previously characterized (Jiang et al.,
2000; Serbedzija and McMahon, 1997) and is known to direct
expression in neural crest cells in a pattern that overlaps with Pax3
(Brown et al., 2001; Jiang et al., 2000).
Wnt1-cre, Pax3NCE-neo/− mice were born alive, but died immedi-
ately after birth. The pups appeared cyanotic and were smaller than
wild-type littermates. Limb and diaphragm musculature were poorly
developed and the pups failed to initiate respirations, as evidenced
by lungs that were not inﬂated (data not shown). Occasional mild
spina biﬁda was present (Figs. 4A and B), likely due to the difference
in temporospatial expression patterns between Pax3 and Wnt1-cre
in the neural crest domain (Supplemental Fig. 2). Hematoxylin and
eosin staining of tissue sections through the right ventricular outﬂow
tract of rescued pups revealed no evidence of persistent truncus
arteriosus (Figs. 4C and D), while skeletal muscle was severely
deﬁcient in the limbs (Figs. 4E and F). We conclude that tissue-
speciﬁc rescue of Pax3 expression in the Wnt1-cre expression
domain is sufﬁcient to rescue embryonic development, but fails to
rescue skeletal muscle formation.Identiﬁcation of a potentially redundant neural crest enhancer
As deletion of the previously characterized neural crest enhancer,
NCE, from the Pax3 locus failed to perturb neural crest development,
we sought to identify other potentially redundant enhancers. Previous
efforts to identify Pax3 regulatory elements have focused on the
genomic regions upstream of the ﬁrst exon. We therefore concen-
trated on intronic and downstream sequences to identify novel Pax3
enhancers. We hypothesized that such cis-acting elements may be
well conserved in evolution. We used the NCBI DCODE comparative
genomics resource (http://www.dcode.org) to identify 8 evolution-
arily conserved regions (ECRs) in the Pax3 locus (Supplemental Fig.
3A). The ECRs were deﬁned by a minimum length of 200 bp, and a
minimum identity of 50% between the mouse and chicken syntenic
regions. The elements ranged in size from ∼400 bp to 1 Kb. Each of
these elements was PCR ampliﬁed and subcloned upstream of the
hsp68 minimal promoter and lacZ. Transient transgenic mice were
generated and analyzed at E10.5 for reporter activity.
Two ECRs resulted in reproducible patterns that recapitulated
aspects of endogenous Pax3 expression (Supplemental Fig. 3B). ECR2
(Supplemental Fig. 3C) and ECR 4 are both in the 4th intron and each
confers dorsal neural tube expression in transgenic embryos. The
expression seen from ECR2 (Figs. 5A and B) was more robust, and
extended to the dorsal extreme or the neural tube unlike the pattern
seen with ECR4 (data not shown). Therefore, we sought to analyze
ECR2 in more detail.
Fig. 5. ECR2 directs neural crest expression in transgenic mouse embryos. (A) Schematic representation of the region of the Pax3 locus containing the NCE (orange box) and ECR2
(red box). Black boxes represent exons. Three transgene constructs are depicted using ECR2 with the hsp68 minimal promoter as well as Pax3 upstream sequence with and without
the NCE. (B) E10.5 transient transgenic embryo showing strong dorsal neural tube expression throughout the anterior-posterior axis. (C) The same pattern is seen in the stable line
with Construct 1. (D) Transient transgenic embryo with ECR2 and the 1.6 Kb Pax3 upstream region shows robust dorsal neural tube expression. (E) Transient transgenic embryo
showing dorsal neural tube expression despite the removal of the NCE from the Pax3 upstream sequence.
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which recapitulated the expression pattern of transient transgenic
embryos (Fig. 5C, Supplemental Fig. 4). ECR2 gives robust expression
along the antero-posterior axis of the neural tube, unlike the more
variable pattern seen with related transgenic constructs containing
the upstream NCE (Li et al., 1999; Milewski et al., 2004; Natoli et al.,
1997). We tested ECR2 in combination with the Pax3 1.6 Kb upstream
genomic region that contains the NCE and the minimal Pax3 promoter
(Li et al., 1999) which replaces the hsp68 promoter (Figs. 5A and D,
Supplemental Fig. 3B). Again, dorsal neural tube expression was
detected along the entire anteroposterior axis in a pattern that
recapitulates endogenous Pax3 expression (Fig. 5D). Next, we sought
to eliminate activity of the NCE in the setting of this transgene in order
to determine if ECR2, like NCE, is able to functionwith the endogenous
minimal Pax3 promoter to drive dorsal neural tube expression. We
have previously shown that deletion of the NCE in the context of the
1.6 Kb upstream Pax3 genomic region is sufﬁcient to eliminate
expression (Milewski et al., 2004). However, deletion of the NCE in
the context of the related construct that also contains ECR2 (Fig. 5A,
Construct 3) failed to eliminate neural crest expression (Fig. 5E).
Taken together, these observations demonstrate redundancy of cis-regulatory elements in the Pax3 locus that direct neural crest
expression, at least in the context of our transgenic analysis.
Analysis of Lef1 sites in ECR2 using zebraﬁsh
Although direct sequence comparisons of the upstream NCE and
ECR2 failed to identify signiﬁcant homology, more sophisticated
analysis revealed conserved motifs. We used rVista version 2.0 (Loots
and Ovcharenko, 2004) to identify NFY and Lef1/TCF binding sites
that are conserved between mouse and chicken genomes, and also
present in both the NCE and ECR2. NFY and Lef1/TCF sites occur
within 60 bp of each other in both enhancers. Wnt signaling has been
shown to function upstream of Pax3 expression, although direct
activation of Pax3 expression via Lef/TCF binding has not been
demonstrated (Bang et al., 1999; Burstyn-Cohen et al., 2004; Taneyhill
and Bronner-Fraser, 2005). In order to test the functional signiﬁcance
of the Lef/TCF sites identiﬁed in ECR2 (Supplemental Fig. 5) we
utilized the zebraﬁsh model system because of the ability to rapidly
produce and assess transgenic expression and to co-express multiple
transgenic constructs in a single embryo. ECR2 directs expression of
the reporter genes mCherry and EGFP, in the dorsal neural tube of
Fig. 6. Analysis of transgenic zebraﬁsh shows that ECR2 directs expression to the dorsal neural tube and that this expression requires Lef1/TCF sequences. (A1–A4) Lateral view of a
1-dpf zebraﬁsh embryo that is stably transgenic for Sox10:EGPF and transiently transgenic for ECR2:mCherry demonstrates strong dorsal neural tube expression (yellow
arrowheads). (B1–B4) Dorsal view of a similarly injected embryo as shown in column A. (C1–C4) Lateral view of a 24-hpf zebraﬁsh embryo that is stably transgenic for Sox10:EGPF
and injected with an ECR2ΔLef:mCherry transgene shows that mutations in the Lef1/TCF sequences abrogates expression. (D1–D4) Lateral view of a 24-hpf zebraﬁsh embryo that has
been injected with both ECR2:EGFP and ECR2ΔLef:mCherry transgenes shows EGFP expression in the dorsal neural tube (yellow arrowheads). Despite effective transposase activity,
no mCherry expression is detected. Scale bar=500 μm.
525K.R. Degenhardt et al. / Developmental Biology 339 (2010) 519–527zebraﬁsh embryos in a pattern that overlaps with that of Sox10, a
marker of neural crest (Antonellis et al., 2008) (Figs. 6A and B).
Twenty-six of 79 injected embryos showed this expression pattern.
Mutation of the Lef/TCF sites largely abolished expression in this
assay (weak expression or ectopic expression was seen in 1 of 97
injected embryos) (Fig. 6C). Furthermore, co-injection of wild-type
ECR2 driving EGFP expression with a mutant form of ECR2 lacking
Lef/TCF binding sites driving mCherry expression resulted in 36
embryos with dorsal neural tube expression of EGFP, while none
expressed mCherry (Fig. 6D). Thus, intact Lef/TCF sites are required
for enhancer activity of ECR2 in this system.
Discussion
In this report, we provide evidence for redundancy among
enhancer elements that mediate dorsal neural tube and neural crest
expression of Pax3. Our prior studies have indicated that the upstream
neural crest enhancer regions are not only able to direct expression of
a marker gene to the dorsal neural tube but are also able to direct
functional expression of Pax3 to the neural tube and neural crest.
Thus, Pax3-deﬁcient Splotch embryos that express transgenic Pax3
from these elements exhibit functional rescue that includes neural
tube closure and proper septation of the cardiac outﬂow tract (Li et al.,
1999).
To our surprise, however, our present studies indicate that these
upstream enhancer elements are, to the best of our ability to test,
completely dispensable for normal Pax3 expression and function.
Mice with homozygous deletion of the upstream neural crest
enhancer elements develop normally, exhibited normal Pax3 protein
expression in all tissues examined, and fail to display any discernable
phenotypes. When crossed to Splotch to produce Pax3Sp/NCE mice in
order to examine the NCE allele on a sensitized background, thephenotype is indistinguishable from Pax3Sp/+ (that is, only a white
belly spot is seen) (data not shown). Our attempts to measure Pax3
transcriptional activity using a Pax3-reporter mouse also show
normal function of the NCE allele. Thus, we conclude that the NCE
enhancer region is sufﬁcient to mediate neural crest expression of
Pax3, but is not necessary.
This conclusion led us to search for and identify potentially
redundant enhancer regions that could mediate neural crest expres-
sion of Pax3 in the absence of NCE. Our data suggest that a redundant
enhancer, ECR2, exists within intron 4.
The literature is replete with examples of functional redundancy
among genes, and biologists generally accept the notion that
redundant coding regions protect organisms and species from the
detrimental effects of random mutation (Blackwood and Kadonaga,
1998; Krakauer and Nowak, 1999; Raes and Van de Peer, 2003).
However, examples of functional redundancy among enhancer
elements are less common. This is likely to be primarily due to the
fact that fewer enhancer elements have been targeted for deletion by
homologous recombination, and it may also be due to under-
reporting of benign phenotypes after enhancer inactivation. However,
functional redundancy among regulatory control regions provides
theoretical protection to the organism against mutation of critical
sequences that might otherwise result in detrimental phenotypes,
perhaps contributing to the persistence of this type of redundancy
through evolution. Indeed, distant but functionally overlapping
control elements regulate expression of MyoD, and speciﬁc deletion
by homologous recombination of one of these elements results in
relatively subtle defects (Chen and Goldhamer, 2004; Chen et al.,
2002). Functional redundancy of enhancer elements in the T-cell
receptor (TCR) gamma locus has been demonstrated by gene
targeting, although in this case the individual enhancers display
both overlapping and unique functions (Xiong et al., 2002).
526 K.R. Degenhardt et al. / Developmental Biology 339 (2010) 519–527Our studies do not rule out the possibility that the upstream NCE
and ECR2 possess distinct, in addition to partially overlapping,
functions. We have not inactivated ECR2 by homologous recombina-
tion in order to assess the necessity for this element, and it remains
possible that additional partially redundant enhancers exist that also
control Pax3 expression in the neural tube and neural crest. Indeed,
ECR4, described in this study, may serve such a purpose. Furthermore,
it is possible that on different genetic backgrounds or under different
environmental conditions the upstream NCE displays unique regula-
tory characteristics distinct from those of ECR2. For example, the
upstream NCE is responsive to retinoic acid (Natoli et al., 1997) and
both vitamin A and folate exposure can affect Pax3 expression and
related neural crest phenotypes (Bang et al., 1997; Burren et al., 2008;
Fleming and Copp, 1998; Wlodarczyk et al., 2006). Perhaps mice
lacking either the upstream NCE or ECR2 would be more or less
sensitive to genetic or environmental perturbations in vitamin A,
folate, or other signals. Such a mechanism could also contribute to
evolutionary pressure to conserve these elements.
We identiﬁed evolutionary conservation of NFY and Lef1/TCF
binding sites in the two redundant neural crest enhancers within the
Pax3 locus. We focused our attention on the functional signiﬁcance of
the conserved Lef1/TCF bindings sites, which we demonstrated using
transgenic zebraﬁsh. Evidence in the published literature suggests
that the NFY binding sites may also be functionally signiﬁcant. For
example, the NFY site in the NCE overlaps with a Pbx1 site that has
previously been shown to directly regulate expression of Pax3 both in
vitro and in vivo (Chang et al., 2008; Pruitt et al., 2004). Pbx1 binds to
the upstream neural crest enhancer and activates expression of a
reporter gene in transfection assays (Chang et al., 2008; Pruitt et al.,
2004) and expression of the 1.6 Kb Pax3 transgene is diminished in
Pbx1−/− embryos (Chang et al., 2008). Mutation of a Pbx1 binding site
within the 1.6 Kb promoter/enhancer region largely abrogates neural
tube expression (Chang et al., 2008).
We searched for related enhancer sequences elsewhere in the
genome. Using synoR analysis (Ovcharenko and Nobrega, 2005),
potential regulatory modules containing NFY and Lef1/TCF bindings
sites, within a 60 bp span, conserved between mouse and chicken are
identiﬁed in 594 locations in the mouse genome. Eight of these
modules are identiﬁed in the proximal upstream region of known
genes and 197 modules are found in intronic regions of known or
predicted genes. This analysis identiﬁes several genes known to be
expressed in the neural crest, including Meis2, Msx2, and Mef2C.
The targeting procedure that we adopted to delete the NCE
fortuitously resulted in the creation of a new allele of Splotch when
the ﬂoxed PGK-neo cassette was inserted in place of the targeted
enhancer sequences. The dramatic impairment of Pax3 mRNA and
protein expression induced by insertion of this cassette was likely due
to promoter competition produced by the presence of the PGK
sequences. The NCE-neo allele allows for tissue-speciﬁc rescue of Pax3
expression by cre-mediated recombination. By crossing mice carrying
the NCE-neo allele with those in which Cre had been knocked into the
Pax3 locus, we were able to dramatically rescue near normal Pax3
expression and embryonic development. Neural crest-speciﬁc exci-
sion of the neo cassette resulted in rescue of neural crest-related
embryonic defects such as neural tube closure and cardiac septation.
This result suggests a neural-crest autonomous role for Pax3 with
respect to these phenotypes, a conclusion that has been previously
challenged by mouse-chick transplantation studies suggesting that
Pax3 expression in the somite adjacent to neural crest migratory
pathways might contribute to neural crest defects in Splotch
(Serbedzija and McMahon, 1997). Furthermore, we have previously
described an upstream Pax3 enhancer that mediates hypaxial somite
expression and we have generated transgenic mice expressing Cre
recombinase in this domain (Brown et al., 2005). By crossing these
mice with the NCE-neo allele, we restored Pax3 expression to the
hypaxial somite, but failed to rescue either neural crest or skeletalmuscle development (data not shown), suggesting that expression of
Pax3 in this domain was insufﬁcient to support normal neural crest
development, and that Pax3 expression in somitic precursors is likely
to be required before specialization of the hypaxial domain.
In conclusion, this study highlights the complexity of transcrip-
tional regulatory control of gene expression and, in particular, the
need to examine enhancer function in the context of the endogenous
chromosome. Transgenic assays for sufﬁciency should not be confused
with rigorous tests for necessity. Furthermore, the lack of overt
similarities between two distinct Pax3 enhancers with overlapping
function underscores our lack of sophisticated insight into regulatory
code and our relatively poor ability to predict enhancer function from
sequence. Further detailed analysis of functional redundancy among
enhancers will be necessary in order to alleviate these weaknesses.
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